PROGENRA

Progenra pursues novel approaches to exploit the ubiquitin proteasome system for drug discovery in numerous therapeutic areas. Its UbiPro™ Drug Discovery Platform is a multi-faceted approach based on the physiological milieux in which enzymes of the ubiquitin proteasome system interact with their substrates. This approach has led to breakthroughs in developing drug candidates for evaluation and progression in the clinic. Progenra’s expertise in developing small molecule E3 ligase modulators ... is being harnessed to create novel classes of PROTAC molecules to expand the scope of this promising new avenue of proteostasis-based therapeutics. Progenra’s mission is to leverage its expertise in the ubiquitin proteasome system and cellular protein regulation, acquired over several years, to discover and develop novel, first in class medicines to fill unmet needs in a spectrum of therapeutic areas.

#SimilarOrganizations #People #Website #More

PROGENRA

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2002-01-01

Address:

Malvern, Pennsylvania, United States

Country:

United States

Website Url:

http://www.progenra.com

Total Employee:

11+

Status:

Active

Contact:

610.644.6974

Email Addresses:

[email protected]

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress